Research Studies
Back to Results
VA Protocol: Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia
Description
Adults diagnosed with schizophrenia are needed for a clinical trial to learn more about how a new medication may affect the brain. Study participants will complete MRI scans, clinical interviews, and cognitive tests. Duration of participation: 14 weeks. Participants will be compensated for their time.
MoreDetails
Age
Adult
Eligibility
Volunteers must have a diagnosis of schizophrenia or schizoaffective disorder.
Detailed Eligibility: Volunteers must be between 18-70 years old, have a diagnosis of schizophrenia or schizoaffective disorder, not have metal or electronic devices in their body and not be claustrophobic.
Phase
IV - Research Studies occurring after FDA has approved a drug for marketing. These studies gather additional information about a drug's safety, efficacy, or optimal use.
Type of Study
Treatment
Location
University of Colorado Hospital
Principal Investigator
Jason Tregellas
Study ID
Protocol Number: 16-1831
More information available at ClinicalTrials.gov: NCT03034356
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers